T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
Although advances in preventive medicine have greatly improved prognosis, cardiovascular disease (CVD) remains the leading cause of death worldwide. This clearly indicates that there remain residual cardiovascular risks that have not been targeted by conventional therapies. The results of multiple a...
Main Authors: | Kohsuke Shirakawa, Motoaki Sano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2435 |
Similar Items
-
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
by: Kohsuke Shirakawa, et al.
Published: (2023-01-01) -
The role of autoantibodies in bridging obesity, aging, and immunosenescence
by: Taylor R. Valentino, et al.
Published: (2024-11-01) -
Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications
by: Ludmila Müller, et al.
Published: (2024-06-01) -
Immunosenescence Study of T Cells: A Systematic Review
by: Ivon Johanna Rodriguez, et al.
Published: (2021-01-01) -
A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases
by: Yuanyuan Wang, et al.
Published: (2021-06-01)